Home > Pressrelease > Adaptogens Market size to surpass USD 19 billion by 2032

Adaptogens Market size to surpass USD 19 billion by 2032

  • Published Date: December 20, 2022

Adaptogens Market Size will be valued at over USD 19 Billion by 2032, according to a recent research report announced by Global Market Insights Inc.

Rising demand for pharmaceutical products has resulted in increased production scales, which has powered global adaptogens market forecast. Adaptogens can boost overall health and specifically help relieve mental and physical fatigue that can come with stress. Additionally, it can reduce the pain and inflammation caused by osteoarthritis and rheumatoid arthritis (RA).

Over the past few years, the deadly COVID-19 pandemic has stressed the importance of maintaining good eating habits for immunity building. As a result, dependence on natural foods has surged, owing to their numerous health benefits. Certain plants and adaptogens have captured the attention of consumers wishing to boost their disease resistance. This trend has encouraged many pharmaceutical firms to invest in product R&D for manufacturing medications with adaptogens.

Personal care benefits to fuel the uptake of schisandra in the global industry

Adaptogens market share from schisandra segment is expected to grow with a CAGR of 6.5% through 2032. Thanks to the ingredient’s astringent qualities, it finds wide application in skincare products. Astringent helps to enhance skin glow by holding its moisture and reducing fine lines. Additionally, the usage of schisandra also imparts shine and thickness to the hair. It is effective in treating insomnia, which makes it an important ingredient of sleep-support supplements. As per sleep foundation, over 30% to 48% of older adults have insomnia. The rising demand for sleep support supplements is also likely to influence schisandra uptake in the beauty and healthcare industry.

Rising need to enhance nutritional value of food to drive adoption of powder adaptogens

Global adaptogens market share from powder segment is poised to be worth over USD 8.5 billion by 2032. The inclusion of adaptogens as a part of healthy diets has witnessed a steady growth in recent times. Adaptogens are known for improving attention, combating the effects of stress, boosting immune system and improving energy levels when consumed in diets. Since they have a bitter taste, people prefer consuming it in powdered form where it can be added to various drinks or can be sprinkled on food to make the food more nutritious.

Browse key industry insights spread across 270 pages with 302 market data tables and 21 figures & charts from the report “Adaptogens Market Statistics By Source (Ashwagandha, Ginseng, Astragalus, Holi Basil, Rhodiola Rosea, Schisandra, Adaptogenic mushrooms), By End-Use (Powder, Capsule, Tea & Beverages), By Application (Food & Beverages, Dietary Supplements, Pharmaceuticals, Cosmetics, Animal Feed), By Distribution Channel (Offline {Supermarkets/Hypermarkets, Drugstore, Grocery & convenience store}, Online), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032”, in detail along with the table of contents:

Growing application-base in the pharmaceutical industry to drive adaptogens demand

Adaptogens market share from pharmaceutical segment is projected to be valued at more than USD 3.5 billion by 2032. With potential health benefits ranging from a stronger immune system, improved endurance, more energy, and better stamina, consumer interest in adaptogens has grown multifield over the last few years. They are expected to see significant demand in the coming years as consumers look to manage heightened levels of stress and anxiety post the pandemic. As per estimates from the we forum, nearly 275 million people suffer from anxiety disorders globally.  Since adaptogens can manage both, physical and mental stressors, they are increasingly being used in the pharmaceutical industry.

Higher application in skincare to boost Europe adaptogens market landscape

Europe adaptogens industry size is expected to surpass USD 4 billion by 2032. The use of natural ingredients in skin care and cosmetic products is fuelling the market expansion. The use of adaptogens in skincare is said to soothe irritation and thwart signs of aging. The idea is that adaptogens help the body to adapt to all the stressors of life, such as pollution, UV rays, and oxidation, etc., so it can better fend them off. Such product benefits are likely to foster their usage in the industry in the coming years.

Competitive landscape of global adaptogens market share

REBBL, Organic India, Nutra Science Labs, Nutracap Labs, Organika Health Products Inc, PLT Health Solutions, Xi’an Greena Biotech Co. Ltd., Organic Herb Inc, Xian Yuensun Biological Technology Co. Ltd., and UNO VETCHEM are considered as the leading adaptogen companies operating in the market. In an attempt to retain themselves in today’s competitive environment, these companies are leveraging the power of ecommerce and awareness programs to reach out to a newer customer base.

Authors: Kunal Ahuja, Sarita Bayas